Warning on increased serious health complications related to non-medical use of nitrous oxide
Therapie
.
2021 Sep-Oct;76(5):478-479.
doi: 10.1016/j.therap.2020.01.002.
Epub 2020 Jan 17.
Authors
French Association of Addictovigilance Centres
1
;
Joelle Micallef
2
,
Michel Mallaret
3
,
Maryse Lapeyre-Mestre
4
,
Amélie Daveluy
5
,
Caroline Victorri-Vigneau
6
,
Hélène Peyrière
7
,
Danièle Debruyne
8
,
Sylvie Deheul
9
,
Régis Bordet
9
,
Cécile Chevallier
10
,
Marie-Christine Perault-Pochat
11
,
Reynald Le Boisselier
8
,
Frédéric Libert
12
,
Leila Chaouachi
13
,
Pierre Gillet
14
Affiliations
1
CHU de Bordeaux, 33076 Bordeaux, France.
2
CEIP-Addictovigilance Marseille, 13385 Marseille, France. Electronic address:
[email protected]
.
3
CEIP-Addictovigilance Grenoble, 38043 Grenoble, France.
4
CEIP-Addictovigilance Toulouse, 31000 Toulouse, France.
5
CEIP-Addictovigilance de Bordeaux, CHU de Bordeaux, Bordeaux, France.
6
CEIP-Addictovigilance Nantes, 44093 Nantes, France.
7
CEIP-Addictovigilance Montpellier, 34295 Montpellier, France.
8
CEIP-Addictovigilance Caen, 14033 Caen, France.
9
CEIP-Addictovigilance Lille, 59037 Lille, France.
10
CEIP-Addictovigilance Lyon, 69460 Lyon, France.
11
CEIP-Addictovigilance Poitiers, 86021 Poitiers, France.
12
CEIP-Addictovigilance Clermont-Ferrand, 63003 Clermont-Ferrand, France.
13
CEIP-Addictovigilance Paris, 75475 Paris, France.
14
CEIP-Addictovigilance Nancy, 54511 Nancy, France.
PMID:
32063400
DOI:
10.1016/j.therap.2020.01.002
No abstract available
Keywords:
Addictovigilance; Nitrous oxide; Polyneuropathies; Vitamin B12.
Publication types
Letter
MeSH terms
Humans
Nitrous Oxide* / adverse effects
Substances
Nitrous Oxide